Hansa Biopharma AB
HNSA SE0002148817
ICB 2010 : Health Care / Health CareAnnual Performance 1
2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|
-69% | -30% | -31% | 47% | -9% |
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
Person | Price | Shares | Total | Published | Completed |
---|---|---|---|---|---|
Peter Nicklin CB |
30.64 SEK |
17,067 Bought |
522,933 SEK |
12/08/2025 | 05/08/2025 |
Renée Aguiar Lucander CEO |
27.40 SEK |
50,000 Bought |
1,370,000 SEK |
29/07/2025 | 28/07/2025 |
Renée Aguiar Lucander CEO |
27.00 SEK |
100,000 Bought |
2,700,000 SEK |
29/07/2025 | 24/07/2025 |
Anne Säfström Lanner EX OFF |
26.42 SEK |
8,056 Sold |
212,840 SEK |
24/07/2025 | 22/07/2025 |
Anne Säfström Lanner EX OFF |
42.27 SEK |
10,487 Sold |
443,285 SEK |
25/06/2024 | 17/06/2024 |
Sören Tulstrup CEO |
42.27 SEK |
9,199 Sold |
388,842 SEK |
21/06/2024 | 17/06/2024 |
Peter Nicklin CB |
38.88 SEK |
10,000 Bought |
388,800 SEK |
08/02/2024 | 06/02/2024 |
Sören Tulstrup CEO |
23.03 SEK |
5,000 Bought |
115,142 SEK |
08/12/2023 | 07/12/2023 |
Peter Nicklin CB |
71.19 SEK |
14,500 Bought |
1,032,193 SEK |
02/08/2022 | 19/07/2022 |
Henk Doude Van Troostwijk O |
49.99 SEK |
2,591 Sold |
129,524 SEK |
22/06/2022 | 17/06/2022 |